The cytotoxic mechanisms of NK cell action are mediated predominantly via perforin and granzymes, which are essential effector molecules for NK cell cytotoxic activity 5,6
The dosing framework comes from extrapolation: murine studies scaled by body surface area, in vitro keratinocyte studies reverse-engineered to estimate required serum concentration, and anecdotal protocols from research communities using off-label peptides
BPC-157 (Body Protection Compound), TB-500 ( Thymosin-4) TB-500 BPC-157
9 The GLP-1RA (glucagon-like peptide-1 receptor agonist), semaglutide, is approved at a dose of 2.4 mg once weekly, administered subcutaneously, for long-term weight management and cardiovascular risk reduction
Insilico Medicine developed a novel oncology drug candidate using a deep learning platform for target identification and molecule generation